Abstract
The decision to treat elevated arterial pressure in pregnancy depends on the risk and benefits imposed on the mother and the fetus. Treatment for mild-to-moderate hypertension during pregnancy may not reduce maternal or fetal risk. Severe hypertension, on the other hand, should be treated to decrease maternal risk. Methyldopa and beta-adrenoceptor antagonists have been used most extensively. In acute severe hypertension, intravenous labetalol or oral nifedipine are reasonable choices.
MeSH terms
-
Acute Disease
-
Adrenergic alpha-Antagonists / adverse effects
-
Adrenergic alpha-Antagonists / therapeutic use
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Antihypertensive Agents / adverse effects*
-
Antihypertensive Agents / therapeutic use
-
Calcium Channel Blockers / adverse effects
-
Calcium Channel Blockers / therapeutic use
-
Diuretics / adverse effects
-
Diuretics / therapeutic use
-
Female
-
Humans
-
Hypertension, Pregnancy-Induced / drug therapy*
-
Hypertension, Pregnancy-Induced / physiopathology
-
Lactation / physiology*
-
Pregnancy / physiology*
-
Renin-Angiotensin System / drug effects
Substances
-
Adrenergic alpha-Antagonists
-
Adrenergic beta-Antagonists
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Diuretics